Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery (ORSY)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05174910 |
|
Recruitment Status :
Recruiting
First Posted : January 3, 2022
Last Update Posted : May 12, 2023
|
Sponsor:
Vivostat
Collaborators:
Raffeiner GmbH
AF Schimetta GMbH
Rivolution GmbH
European Commission
Information provided by (Responsible Party):
Vivostat
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2024 |
| Estimated Study Completion Date : | December 2024 |